Clinical studies on the short-course and efficient treatment of mumps meningitis.
- Author:
Min ZHAO
1
;
Tianjun JIANG
;
Jumei CHEN
;
Xianzhi ZHOU
;
Zhiping ZHOU
Author Information
- Publication Type:Clinical Trial
- MeSH: Anti-Inflammatory Agents; therapeutic use; Child; Child, Preschool; Dexamethasone; therapeutic use; Female; Humans; Infant; Injections, Spinal; Male; Meningitis, Viral; complications; drug therapy; Mumps; complications; drug therapy; Treatment Outcome
- From: Chinese Journal of Experimental and Clinical Virology 2002;16(4):388-389
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the short-course and efficient way to treat mumps meningitis.
METHODSTotally 155 cases of mumps meningitis treated by intrathecal injection with dexamethasone only once were enrolled as experimental group and 55 similar cases treated with the common therapy as control.
RESULTSThe time for recoveries of temperature, headache, the pathologic reflexes and the total time of treatment were 32 hours, 15 hours, 12 hours and 3.1 days, respectively, while those of the control group were 58 hours, 24 hours, 32 hours, 6.5 days respectively. There was statistical difference between the two groups (P<0.01 or 0.05).
CONCLUSIONSIntrathecal injection with dexamethasone only once is efficient and safe in the treatment of mumps meningitis.
